Cas:6812-78-8 (3S)-3,7-dimethyloct-7-en-1-ol manufacturer & supplier

Chemical Name:(3S)-3,7-dimethyloct-7-en-1-ol

CAS.NO:6812-78-8

Synonyms:3,7-dimethyl-7-octen-1-ol;(S)-3,7-Dimethyl-7-octen-1-ol;3,7-dimethyl-7-octenol;Rhodinol,(-);7-Octen-1-ol,3,7-dimethyl-,(S);EINECS 229-887-4;1-citronellol;FEMA No. 2980;3,7-dimethyl-oct-7-en-1-ol;1-hydroxy-3,7-dimethyl-7-octene;Rhodinol (natural)

Molecular Formula:C₁₀H₁₃ClN₆O₆S

Molecular Weight:380.76500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:68-70ºC1.8 mm Hg(lit.)

Density:0.865 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.469(lit.)

PSA:197.08000

Exact Mass:380.03100

LogP:0.26350

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,7-dimethyl-7-octen-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Rhodinol (natural) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 229-887-4 Use and application,(S)-3,7-Dimethyl-7-octen-1-ol technical grade,usp/ep/jp grade.

Related News: Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. (3S)-3,7-dimethyloct-7-en-1-ol manufacturer The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. (3S)-3,7-dimethyloct-7-en-1-ol supplier With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow. (3S)-3,7-dimethyloct-7-en-1-ol vendor The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself. (3S)-3,7-dimethyloct-7-en-1-ol factory With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.